Janux Therapeutics(JANX) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

JANX Janux Therapeutics

Watchlist

29.940
-0.490-1.61%

Close Mar 21 16:00 ET

30.180
+0.240+0.80%

Post 20:01 ET

1.77BMarket Cap-23.39P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

JonesTrading Maintains Janux Therapeutics(JANX.US) With Buy Rating, Cuts Target Price to $90
Moomoo NewsMar 15 14:31 ET · Ratings
WEX, Lamb Weston, and More Stocks See Action From Activist Investors -- Barrons.com
Barron'sMar 14 18:17 ET
Buy Rating for Janux Therapeutics: Promising Technology and Strong Financial Position Amid Competitive Pressure
TipRanksMar 14 16:15 ET
Ra Capital Management Buys $25.3 Million in Janux Therapeutics Stock
InvestingMar 7 18:10 ET
Janux Therapeutics(JANX.US) 10% Shareholder Buys US$25.34 Million in Common Stock
Moomoo NewsMar 7 18:07 ET
Analysts' Top Healthcare Picks: Xenon (XENE), Janux Therapeutics Inc (JANX)
TipRanksMar 6 08:00 ET · Ratings

Comments

74425369

Mar 10 19:40

INSIDER BUY ALERT: JANX

What happened: In recent weeks, $Janux Therapeutics (JANX.US)$ has seen significant insider buying, notably from RA Capital Management, which acquired shares worth approximately $25.3M.
Big picture: Janux's stock has been volatile, trading near its 52-week low. Investor sentiment remains cautious amidst broader biotech sector challenges.
Key Developments:
📊 Positive Clinical Data: JANX007 showed impressive results in Phase 1 trials for metastatic castration-resistant prost...

Kevin Travers

Dec 4, 2024 05:20

Columns Fresh Closing Highs from S&P 500 and Nasdaq | Wall Street Today

After pulling back during the day, the S&P 500 and Nasdaq hit fresh closing highs- and the Nasdaq hit a trading high of 19,486.15.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ climbed 0.05%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.17%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.40%.
MACRO
JOLTS job openings from the Bureau of Labor Statistics came in at 7.74M, higher than last month's number, but ever since Ap...

Market eyes Non-Farm data: Will there be a rate cut in Dec?

Rivera

Dec 3, 2024 05:50

Up up

$Janux Therapeutics (JANX.US)$

Stock_Drift

Dec 3, 2024 05:45

After Hours Ticks 5:44pm 12/2

$CytomX (CTMX.US)$ $Onconetix (ONCO.US)$ $Edesa Biotech (EDSA.US)$ $XBP Europe Holdings (XBP.US)$ $Nauticus Robotics (KITT.US)$ $Alset (AEI.US)$ $Carmell (CTCX.US)$ $Jayud Global Logistics Ltd. (JYD.US)$ $Vir Biotechnology (VIR.US)$ $Shimmick (SHIM.US)$ $Credo Technology (CRDO.US)$ $Janux Therapeutics (JANX.US)$ $Citius Oncology (CTOR.US)$ $Volato Group (SOAR.US)$
📊⚡️📊

103280143

Nov 18, 2024 21:51

A Glimpse into My 2025 Stock Picks (US Edition)

As we enter 2025, the U.S. stock market presents a landscape ripe with opportunities. The Federal Reserve's recent meeting minutes indicate a cautious yet optimistic approach, suggesting that while inflationary pressures are being monitored, the overall economic outlook remains positive. This balanced stance bodes well for investors seeking growth in the coming year.
Janux Therapeutics Inc. (NASDAQ: JANX)
Janux Therapeutics is a clinical-stage bioph...